View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
November 15, 2018updated 22 Nov 2018 11:19am

Bay Labs and Northwestern study AI for heart disease detection

Bay Labs has partnered with Northwestern Medicine to assess the artificial intelligence (AI) based EchoGPS cardiac ultrasound guidance software suite for the detection of heart disease through cardiovascular imaging.

Bay Labs has partnered with Northwestern Medicine to assess the artificial intelligence (AI) based EchoGPS cardiac ultrasound guidance software suite for the detection of heart disease through cardiovascular imaging.

The ‘Seeing the Heart with AI Powered Echo’ (SHAPE) study has started enrolling patients. It will recruit a total of 1,200 participants across Northwestern Medicine sites.

EchoGPS is investigational software in an ultrasound system and leverages AI to help capture echocardiograms by providing real-time guidance to gain cardiac views.

The software suite also includes EchoMD, which has been designed to enable automated review of acquired images.

SHAPE study’s primary objective is to determine whether the EchoGPS software can be used by certified medical assistants (CMAs) without any previous experience to capture quality echocardiograms.

“The EchoGPS and EchoMD product suite has the potential to transform how cardiovascular care can be delivered in healthcare systems.”

The study will further evaluate if the echocardiogram images can be examined by cardiologists using EchoMD software to detect certain types of heart disease in patients aged 65 years and above, during routine physical examinations in a primary care setting.

Bay Labs co-founder and CEO Charles Cadieu said: “The EchoGPS and EchoMD product suite has the potential to transform how cardiovascular care can be delivered in healthcare systems.

“Incorporating our AI software with deep-learning technology into clinical practice could allow non-specialist medical professionals to acquire images to support cardiologist interpretation and clinical decision-making and may lead to improved patient outcomes through earlier detection and monitoring.”

The study is part of an ongoing Bay Labs and Northwestern Medicine collaboration focused on devising new techniques for the use of AI in clinical cardiovascular care.

It is also in line with Northwestern Medicine’s initiative to leverage AI for the study and treatment of cardiovascular disease.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU